Neuren's move to block the market for a session was the right...

Neuren's move to block the market for a session was the right choice this time. I say this because, calmly and with more in-depth evaluation, in my opinion, Hottod is right in his last post today. We actually have made progress, which is now even more tangible. We, myself first, perhaps had extraordinary expectations, but Neuren has obtained an absolutely practicable and pre-planned guideline, in two indications never explored by anyone else. In the balance of benefits/penalties, it can be rightly said that despite a small delay for the animal study, the advantage is that the FDA has decided what it wants and has agreed to collaborate constructively. What is truly important is that we finally have precise guidelines for developing and promoting 2591. Here then is the turning point on the market!!! Now, inevitably, everyone will have to decide which side to take. Those who no longer have the patience and see 2027 as an endless marathon are right to abandon; Those who believe in the project and want to see it through to 2027 will likely see the turning point. I'd say that tomorrow, the old tricksters will be there, those who have realized that with 2591, things are really starting to get serious, and they'll take or increase their positions. On the other side, there will be those who have had 48 hours to calmly understand what kind of investment Neuren is for at least the whole of 2026. Be careful, because the market has already zeroed out Neuren at the price/earnings ratio, which is currently at $14.24; this is also the big news today!!! We're at a starting point, with clear numbers and projects all on the table, for the best assessment of what to do next. Everyone makes their own choice.
Good luck
Just my thoughts